Literature DB >> 25031507

Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease.

B Tirmenstajn-Jankovic1, N Dimkovic2, G Perunicic-Pekovic3, Z Radojicic4, D Bastac5, S Zikic1, M Zivanovic1.   

Abstract

BACKGROUND: Although anemia and renal dysfunction are related to increased natriuretic peptides levels in heart failure patients, less is known about this relationship in asymptomatic predialysis patients with chronic kidney disease (CKD). The aim of this study was to investigate relationship between hemoglobin (Hb) concentration, N-terminal proBNP (NT-proBNP) levels and echocardiographic findings in these patients.
METHODS: The study included 61 patients with CKD stage IV-V (34 male, mean age 62.6 ± 13.6 years) and 22 age- and sex -matched healthy persons as control group. All participants underwent clinical, laboratory and echocardiographic examination, including Tissue Doppler Imaging and colour M-mode Doppler.
RESULTS: Patients with CKD had lower Hb levels (p<0.001), and higher levels of NT-proBNP (p<0.001) than healthy controls. Patients were divided into two groups according to their mean Hb levels: group A, Hb<10.3 g/dL and group B, Hb≥10.3 g/dL. Patients from group A was significantly older (p<0.001), left ventricular mass index was significantly higher (LVMI, p<0.001), LV diastolic function was worse (septal and lateral E'/A' ratio: p<0.05 and p<0.01, respectively), and the level NT-proBNP was higher (p<0.001) compared to patients from group B. The natural logarithm of NT-proBNP (lnNT-proBNP) showed highly significant correlation with Hb (p<0.001) and significant correlation with estimated glomerular filtration rate (p=0.035) in CKD patients. Multiple regression analysis revealed Hb levels (p<0.01), cholesterol (p<0.001), LV ejection fraction (p<0.001) and septal E/E' ratio (p<0.01) as the independent variables predicting as much as 54% variability of lnNTpro-BNP.
CONCLUSIONS: The increased NT-proBNP levels in asymptomatic patients with advanced CKD were independently associated with echocardiographic parameters of LV function, but anemia may represent one of the important confounder of the relationship between NT-proBNP and cardiovascular abnormalities.

Entities:  

Keywords:  NT-proBNP; anemia; chronic kidney disease; left ventricular dysfunction

Year:  2013        PMID: 25031507      PMCID: PMC4097409     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  27 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.

Authors:  U Alehagen; M Janzon
Journal:  Eur J Heart Fail       Date:  2008-03-04       Impact factor: 15.534

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

4.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors:  D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

5.  N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

Authors:  Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
Journal:  Hypertension       Date:  2005-08-29       Impact factor: 10.190

6.  N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.

Authors:  Ijaz A Khan; Jeffrey Fink; Caitlin Nass; Hegang Chen; Robert Christenson; Christopher R deFilippi
Journal:  Am J Cardiol       Date:  2006-03-31       Impact factor: 2.778

7.  Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.

Authors:  Patrick B Mark; Graham A Stewart; Ron T Gansevoort; Colin J Petrie; Theresa A McDonagh; Henry J Dargie; R Stuart C Rodger; Alan G Jardine
Journal:  Nephrol Dial Transplant       Date:  2005-10-12       Impact factor: 5.992

8.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 9.  Cardiac hormones as diagnostic tools in heart failure.

Authors:  Heikki Ruskoaho
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

10.  Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.

Authors:  Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno W Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-05-25       Impact factor: 15.534

View more
  2 in total

1.  Association between Vitamin D Deficiency and Anemia in Patients with End-Stage Renal Disease: A Cross-Sectional Study.

Authors:  Yung Ly Kim; Hyunwook Kim; Young Eun Kwon; Dong Ryeol Ryu; Mi Jung Lee; Kyung Sook Park; Han Jak Ryu; Jung Tak Park; Hyung Jung Oh; Seung Hyeok Han; Tae Hyun Yoo; Shin Wook Kang
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

2.  Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.

Authors:  Lan Chen; Ying-Ying Chen; Yi-Sheng Ling; Chun-Hua Lin; Jin-Xuan He; Tian-Jun Guan
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.